ATE136026T1 - Substituierte bizyklische arylderivate mit selektiver leukotrien b4 antagonistischer wirkung - Google Patents

Substituierte bizyklische arylderivate mit selektiver leukotrien b4 antagonistischer wirkung

Info

Publication number
ATE136026T1
ATE136026T1 AT91917468T AT91917468T ATE136026T1 AT E136026 T1 ATE136026 T1 AT E136026T1 AT 91917468 T AT91917468 T AT 91917468T AT 91917468 T AT91917468 T AT 91917468T AT E136026 T1 ATE136026 T1 AT E136026T1
Authority
AT
Austria
Prior art keywords
pct
selective
leucotrien
bizyclic
substituted
Prior art date
Application number
AT91917468T
Other languages
English (en)
Inventor
Fu-Chih Huang
Wan K Chan
Charles A Sutherland
Robert A Galemmo Jr
Original Assignee
Rhone Poulenc Rorer Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Int filed Critical Rhone Poulenc Rorer Int
Application granted granted Critical
Publication of ATE136026T1 publication Critical patent/ATE136026T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/32—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C07C235/34—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/12—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an alkyl or cycloalkyl radical attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Quinoline Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT91917468T 1990-09-10 1991-09-06 Substituierte bizyklische arylderivate mit selektiver leukotrien b4 antagonistischer wirkung ATE136026T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US58024390A 1990-09-10 1990-09-10

Publications (1)

Publication Number Publication Date
ATE136026T1 true ATE136026T1 (de) 1996-04-15

Family

ID=24320298

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91917468T ATE136026T1 (de) 1990-09-10 1991-09-06 Substituierte bizyklische arylderivate mit selektiver leukotrien b4 antagonistischer wirkung

Country Status (9)

Country Link
US (1) US5468898A (de)
EP (1) EP0548250B1 (de)
JP (1) JP3334087B2 (de)
AT (1) ATE136026T1 (de)
AU (1) AU8641991A (de)
CA (1) CA2091257A1 (de)
DE (1) DE69118388T2 (de)
MX (1) MX9203775A (de)
WO (1) WO1992004321A1 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3058688B2 (ja) * 1990-07-16 2000-07-04 メレルダウファーマスーティカルズ インコーポレイテッド 興奮性アミノ酸拮抗剤
US5076271A (en) * 1990-07-19 1991-12-31 Siemens-Pacesetter, Inc. Rate-responsive pacing method and system employing minimum blood oxygen saturation as a control parameter and as a physical activity indicator
GB9609641D0 (en) * 1996-05-09 1996-07-10 Pfizer Ltd Compounds useful in therapy
US6416733B1 (en) 1996-10-07 2002-07-09 Bristol-Myers Squibb Pharma Company Radiopharmaceuticals for imaging infection and inflammation
JP4713698B2 (ja) 1997-03-05 2011-06-29 スージェン， インク． 疎水性薬剤の処方
JPH10287647A (ja) * 1997-04-11 1998-10-27 Higeta Shoyu Co Ltd 新規インドールアルカロイド系化合物 ００８９−ｄ
US7064114B2 (en) * 1999-03-19 2006-06-20 Parker Hughes Institute Gel-microemulsion formulations
AU7962200A (en) * 1999-10-29 2001-05-14 Wakunaga Pharmaceutical Co., Ltd Novel indole derivatives and drugs containing the same as the active ingredient
AU2002211828A1 (en) * 2000-10-02 2002-04-15 Merck & Co., Inc. Inhibitors of prenyl-protein transferase
CA2427911A1 (en) 2000-11-03 2002-05-10 Bristol Myers Squibb Company Simultaneous dual isotope imaging of cardiac perfusion and cardiac inflammation
US6933316B2 (en) * 2001-12-13 2005-08-23 National Health Research Institutes Indole compounds
US7632955B2 (en) * 2001-12-13 2009-12-15 National Health Research Institutes Indole compounds
US7528165B2 (en) * 2001-12-13 2009-05-05 National Health Research Institutes Indole compounds
WO2003105847A1 (en) * 2002-06-14 2003-12-24 Merck & Co., Inc. Ophthalmic compositions for treating ocular hypertension
JP2005008631A (ja) * 2003-05-29 2005-01-13 New Industry Research Organization ベンゾフラン化合物、およびそれを含有してなる医薬組成物
US20040259926A1 (en) * 2003-06-05 2004-12-23 Bruendl Michelle M. 3-Aryloxy and 3-heteroaryloxy substituted benzo[b]thiophenes as therapeutic agents
EP1636212B1 (de) * 2003-06-05 2007-06-27 Warner-Lambert Company LLC Cycloalkylsulfanyl-substituierte benzo¬b|thiophene als therapeutische mittel
CA2527793A1 (en) * 2003-06-05 2004-12-16 Warner-Lambert Company Llc 3-arylsulfanyl and 3-heteroarylsulfanyl substituted benzo[b]thiophenes as therapeutic agents
CA2527573A1 (en) * 2003-06-05 2004-12-16 Warner-Lambert Company Llc Cycloalkyl and heterocycloalkyl substituted benzothiophenes as therapeutic agents
WO2004108709A1 (en) * 2003-06-05 2004-12-16 Warner-Lambert Company Llc Tetrazol benzofurancarboxamides with p13k aktivity as therapeutic agents
EP1644360A1 (de) * 2003-06-05 2006-04-12 Warner-Lambert Company LLC 3-substituierte indole und ihre derivate als therapeutische mittel
ITRM20030355A1 (it) * 2003-07-18 2005-01-19 Sigma Tau Ind Farmaceuti Composti ad attivita' citotossica derivati della combretastatina.
MXPA06002152A (es) * 2003-09-01 2006-05-22 Ono Pharmaceutical Co Compuesto de anillo condensado y uso del mismo.
CN101076531A (zh) * 2004-10-12 2007-11-21 解码遗传学公司 用于阻塞性血管疾病的羧酸迫位取代的双环化合物
US7456289B2 (en) * 2004-12-31 2008-11-25 National Health Research Institutes Anti-tumor compounds
EP2272832A4 (de) * 2008-04-28 2011-09-07 Asahi Kasei Pharma Corp Phenylpropionsäurederivat und seine verwendung
FR2961812A1 (fr) * 2010-06-29 2011-12-30 Centre Nat Rech Scient Procede de synthese d'alcaloides du type ergoline par double cyclisation a partir de bicycles indoliques, produits obtenus et produits intermediaires
KR101432078B1 (ko) * 2013-04-22 2014-08-21 영남대학교 산학협력단 항병원성 활성을 갖는 7-벤질옥시인돌 화합물의 신규한 용도
RS59934B1 (sr) 2015-06-09 2020-03-31 Abbvie Inc Modulatori nuklearnih receptora (ror) za lečenje inflamatornih i autoimunih oboljenja
CN112321479B (zh) * 2020-11-04 2022-02-08 吉林大学 一种桑寄生中具有抑菌活性的吲哚-4-甲醛化合物、制备方法及其应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2692882A (en) * 1952-04-01 1954-10-26 Upjohn Co (5-benzyloxy-3-indole)-alkanoylamides and preparation thereof
NL271818A (de) * 1960-11-25
US3868405A (en) * 1967-05-17 1975-02-25 Beecham Group Ltd Naphthylene derivatives
FR2230349A1 (en) * 1973-05-23 1974-12-20 Delalande Sa 1-Phenyl-2-methyl-5-methoxy indoles - with e.g. sedative, cardiac analeptic, vasodilator, antihypertensive, analgesic, and antiinflammatory activities
US4814463A (en) * 1985-12-31 1989-03-21 Biomeasure, Inc. CCK antagonists
CA1315279C (en) * 1987-01-12 1993-03-30 Nancy Grace Bollinger Anti-inflammatory agents
CA1320490C (en) * 1987-01-12 1993-07-20 Darrel M. Gapinski Anti-inflammatory agents
US4889871A (en) * 1987-05-29 1989-12-26 G. D. Searle & Co. Alkoxy-substituted dihydrobenzopyran-2-carboxylate derivatives
DE3840338A1 (de) * 1988-11-30 1990-05-31 Bayer Ag Neue 2-halogensubstituierte n-indolylethyl-sulfonsaeureamide, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
US5232948A (en) * 1990-09-10 1993-08-03 Rhone-Poulenc Rorer Pharmaceuticals Inc. Substituted monocyclic aryl compounds exhibiting selective leukotriene b4 antagonist activity
US5210208A (en) * 1990-09-24 1993-05-11 Rhone-Poulenc Rorer Pharmaceuticals Inc. Disubstituted aryl compounds exhibiting selective leukotriene b4 antagonist activity

Also Published As

Publication number Publication date
CA2091257A1 (en) 1992-03-11
DE69118388T2 (de) 1996-11-14
EP0548250A1 (de) 1993-06-30
EP0548250B1 (de) 1996-03-27
JPH06504520A (ja) 1994-05-26
US5468898A (en) 1995-11-21
AU8641991A (en) 1992-03-30
JP3334087B2 (ja) 2002-10-15
MX9203775A (es) 1992-07-01
EP0548250A4 (en) 1993-10-27
WO1992004321A1 (en) 1992-03-19
DE69118388D1 (de) 1996-05-02

Similar Documents

Publication Publication Date Title
DE69118388D1 (de) Substituierte bizyklische arylderivate mit selektiver leukotrien b4 antagonistischer wirkung
PT641328E (pt) Derivados aza-biciclicos em ponte como antagonistas da substancia p
BR9405910A (pt) Piridinas substituídas heterocíclicas herbicidas
DE69213451D1 (de) Fluoralkoxybenzylaminoderivate stickstoffhaltiger heterocyclen
UA26097A1 (uk) Триазиhові похідhі, що мають гербіцидhу активhість, спосіб їх одержаhhя та гербіцидhа композиція hа їх осhові
RU93058531A (ru) Фторалкоксибензиламинные производные азотсодержащих гетероциклов, фармацевтическая композиция, способ лечения
MX9604378A (es) Amidas de acido quinolin-2-carboxilico sustituidas, su preparacion y su empleo como medicamentos, asi como productos intermedios.
PT894084E (pt) Derivados de acido cinamico e sua utilizacao como antagonistas de integrina
BG104544A (en) Novel acylguanadine derivatives as inhibitors of bone resorption and as vitronectin receptor antagonists
ATE227293T1 (de) 2,3-disubstituierte-(5,6)-heteroarylkondensiert - pyrimidin-4-one
DE69516503D1 (de) Piperidinderivate mit paf antagonistischer wirkung
EP0538416A4 (en) Substituted monocyclic aryl compounds exhibiting selective leukotriene b 4? antagonist activity
FI973221A0 (fi) 1-aryyli-2-asyyliammo-etaaniyhdisteitä ja niiden käyttö neurokiniiniantagonisteina, erityisesti neurokiniini 1 antagonisteina
DK0613499T3 (da) Humame IT-4-mutantproteiner
DE69834500D1 (de) Xanthinderivative zur behandlung von hirnischämie
NO972623D0 (no) Framasöytisk blanding omfattende lamotrigin
EP0554313A4 (en) Disubstituted aryl compounds exhibiting selective leukotriene b 4? antagonist activity
NO20010940L (no) TAN-1057 derivater
ATE127021T1 (de) Immunstimulierendes arzneimittel, das polare glycopeptidolipide von mycobakterium-chelonae enthält.
NO305799B1 (no) Nye kinolinderivater, farmas°ytiske preparater inneholdende slike derivater, deres anvendelse samt mellomprodukter
KR910009654A (ko) 아미노피리딘, 아닐린 및 피콜릴아민의 피콜릴셀레노벤즈아미드
IT8124405A0 (it) Derivato dell'indoprofene, processo per la sua preparazione e composizioni terapeutiche che lo comprendono come principio attivo.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties